Home
L1 Capital Global Opportunities Master Fund reported a 4.11% stake in Aeon Biopharma AEON · 465,029 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.11%
- Last report
- 9.99% · filed 25/01/13
- Shares held
- 465,029 sh
- Class
- Class A Common Stock, par value $0.0001 per share
- Stock
- Aeon Biopharma AEON
- Event date
- 25/03/31
- Filed
- 25/05/15
4.11% stake · below 5%
- Stake
- 4.11%
- Last report
- 9.99%
- Since last report
- −5.9pp
Aeon Biopharma trades, last 26 weeks
What else happened in Aeon Biopharma around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30L1 Capital Global Opportunities Master Fund's other 5% stake reports
- L1 Capital Global Opportunities Master Fund
5% stakeBaird Medical Investment Holdings
5% stakeBaird Medical Investment Holdings
BDMD
9.99% stake
3,551,868 sh
9.99% stake
Filed 10/01
- L1 Capital Global Opportunities Master Fund
5% stakeMint
5% stakeMint
MIMI
9.99% stake
1,408,515 sh
9.99% stake
Filed 09/02
- L1 Capital Global Opportunities Master Fund
5% stakeZeta Network Group
5% stakeZeta Network Group
ZNB
9.99% stake
538,443 sh
9.99% stake
Filed 09/01
- L1 Capital Global Opportunities Master Fund
5% stakeNFT
5% stakeNFT
MI
9.8% stake
50,000 sh
9.8% stake
Filed 08/27
- L1 Capital Global Opportunities Master Fund
5% stakeEShallGo
5% stakeEShallGo
EHGO
9.99% stake
464,658 sh
9.99% stake
Filed 08/26
